Peritia — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Peritia is a US-based, private consulting company serving the biotech, pharma, and medtech sectors with end-to-end product development and commercialization services. Founded in 2019, it has rapidly scaled through strategic acquisitions, including BioBridges, Monitorforhire, and CHEORS, creating a unified platform with deep capabilities in clinical operations, HEOR/RWE, and strategic consulting. With a reported history of over 4,000 engagements for more than 700 clients globally, Peritia positions itself as an accelerator for life sciences innovation, combining scientific expertise with agile solutions to de-risk and speed products to market.

Digital HealthAI / Machine Learning

Technology Platform

Integrated life sciences consulting platform combining a scalable network of subject matter experts (clinical, HEOR, strategic) with operational assets for clinical monitoring and evidence generation. Built via acquisition of BioBridges, Monitorforhire, and CHEORS.

Opportunities

The growing complexity and cost of drug development, coupled with the lean operations of many biotechs, creates strong demand for integrated, expert-led consulting services.

The convergence of clinical development and value/access evidence presents a key opportunity for Peritia's combined platform to become a strategic, end-to-end partner.

Risk Factors

Key risks include the operational and cultural challenges of integrating multiple acquired companies, dependence on retaining a decentralized network of expert talent, and intense competition in the life sciences consulting and outsourcing market.

Revenue is also subject to cyclicality based on client R&D spending.

Competitive Landscape

Peritia competes in a fragmented market that includes large global Contract Research Organizations (CROs), boutique specialty consultancies, and functional service providers (FSPs). Its differentiation lies in its integrated model combining strategic consulting, clinical operations, and value/access evidence services through a unified, agile platform.

More companies in Digital Health & Biotech SaaS →More companies in United States →